-
(4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrate
-
ChemBase ID:
154889
-
Molecular Formular:
C29H41N5O9
-
Molecular Mass:
603.66394
-
Monoisotopic Mass:
603.29042792
-
SMILES and InChIs
SMILES:
CC(C)(C)NCC(=O)Nc1cc(c2c(c1O)C(=O)C1=C([C@]3([C@@H](C[C@@H]1C2)[C@@H](C(=C(C3=O)C(=O)N)O)N(C)C)O)O)N(C)C.O
Canonical SMILES:
O=C(Nc1cc(N(C)C)c2c(c1O)C(=O)C1=C(O)[C@]3([C@@H](C[C@@H]1C2)[C@H](N(C)C)C(=C(C3=O)C(=O)N)O)O)CNC(C)(C)C.O
InChI:
InChI=1S/C29H39N5O8.H2O/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36;/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35);1H2/t12-,14-,21-,29-;/m0./s1
InChIKey:
PMPLAEFBZIFHAR-KXLOKULZSA-N
-
Cite this record
CBID:154889 http://www.chembase.cn/molecule-154889.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrate
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
9-t-Butylglycylamido-minocycline hydrate
|
TBG-MINO
|
Tigecyclin
|
Tygacil
|
Tigecycline hydrate
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
0.25205672
|
H Acceptors
|
11
|
H Donor
|
7
|
LogD (pH = 5.5)
|
-5.231753
|
LogD (pH = 7.4)
|
-5.187741
|
Log P
|
-5.147121
|
Molar Refractivity
|
159.3431 cm3
|
Polarizability
|
59.23616 Å3
|
Polar Surface Area
|
205.76 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
PZ0021
|
Other Notes air sensitive Legal Information Sold for research purposes under agreement from Pfizer Inc. Biochem/physiol Actions Tigecycline is a broad spectrum glycylcycline antibiotic. Tigecycline is bacteriostatic, that inhibits protein synthesis by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. Tigecycline is active against resistant strains of gram-positive and gram-negative bacteria, avoiding the two most common mechanisms of resistance to the tetracycline antimicrobials: tetracycline efflux pump proteins and ribosomal protection proteins. |
PATENTS
PATENTS
PubChem Patent
Google Patent